Herd immunity and pneumococcal conjugate vaccine: A quantitative model

This publication has 25 references indexed in Scilit:

• Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment
  The Lancet, 2005
• Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales
  Vaccine, 2004
• Streptococcus pneumoniae colonisation: the key to pneumococcal disease
  The Lancet Infectious Diseases, 2004
• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Macrolide Resistance Among Invasive Streptococcus pneumoniae Isolates
  Published by American Medical Association (AMA) ,2001
• Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998Opportunities for Prevention in the Conjugate Vaccine Era
  JAMA, 2001
• The Emergence ofStreptococcus pneumoniaeResistant to Macrolide Antimicrobial Agents: A 6‐Year Population‐Based Assessment
  The Journal of Infectious Diseases, 2000
• Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children
  JAMA, 2000
• Prospects for pneumococcal vaccination in African children
  Acta Tropica, 2000
• The Prevalence of Drug-ResistantStreptococcus pneumoniaeIn Atlanta
  New England Journal of Medicine, 1995